1. Ahlquist, R.P. A study of the adrenotropic receptor. Amer. J. Physiol., 153, 586–600 (1948).
2. Cession, G., Lecomte, J. and Van Cauwenberghe, H. Action antagoniste de la cinnarizine vis-à-vis de l’angiotensine in vivo. Compt. Rend. Soc. Biol., 158, 1754–1756 (1964).
3. Fleckenstein, A., Tritthart, H. and Fleckenstein, B. A new group of competitive Ca-antagonists (iproveratril, D 600, prenylamine) with highly potent inhibitory effects on excitation-contraction coupling in mammalian myocardium. Pflügers Arch. ges. Physiol., 307, R 25 (1969).
4. Godfraind, R., Kaba, A. and Polster, P. Differences in sensitivity of arterial smooth muscles to inhibition of their contractile response to depolarization by potassium. Arch. Intern. Pharmacodyn. Ther, 172, 235–239 (1968).
5. Haas, H. and Härtfelder, G. ±-lsopropyl-±[(N-methyl-N-homoveratryl)-³-aminopropyl]-3,4-dimethoxyphenyl-acetonitril, eine Substanz mit coronargefässerweiternden Eigenschaften. Arzneimittel — Forsch., 12, 549–553 (1962).